Please enable Javascript to use all features and improve your user experience.
EHC 2023
Programme
People
Search
DE
Back
ePoster
P019
Benefit-Risk assessment of atogepant vs. placebo in participants with episodic migraine who had prior inadequate response to 2–4 classes of oral preventive treatment: a post-hoc analysis of the ELEVATE trial
Uwe Reuter
Berlin, DE
Appointment
Date:
06/12/2023
Time:
19:30
–
19:35
Talk time:
3 Min.
Discussion time:
2 Min.
Location / Stream:
Headache theatre
Poster
Benefit-Risk assessment of atogepant vs. placebo in participants with episodic migraine who had prior inadequate response to 2–4 classes of oral preventive treatment: a post-hoc analysis of the ELEVATE trial
Session
ePoster 02
Topic
New developments in prophylactic medications and acute medications
© Conventus Congressmanagement & Marketing GmbH
Imprint
Privacy